215 related articles for article (PubMed ID: 33515548)
1. A lipid-anchored neurokinin 1 receptor antagonist prolongs pain relief by a three-pronged mechanism of action targeting the receptor at the plasma membrane and in endosomes.
Mai QN; Shenoy P; Quach T; Retamal JS; Gondin AB; Yeatman HR; Aurelio L; Conner JW; Poole DP; Canals M; Nowell CJ; Graham B; Davis TP; Briddon SJ; Hill SJ; Porter CJH; Bunnett NW; Halls ML; Veldhuis NA
J Biol Chem; 2021; 296():100345. PubMed ID: 33515548
[TBL] [Abstract][Full Text] [Related]
2. Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief.
Jensen DD; Lieu T; Halls ML; Veldhuis NA; Imlach WL; Mai QN; Poole DP; Quach T; Aurelio L; Conner J; Herenbrink CK; Barlow N; Simpson JS; Scanlon MJ; Graham B; McCluskey A; Robinson PJ; Escriou V; Nassini R; Materazzi S; Geppetti P; Hicks GA; Christie MJ; Porter CJH; Canals M; Bunnett NW
Sci Transl Med; 2017 May; 9(392):. PubMed ID: 28566424
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief.
Hegron A; Peach CJ; Tonello R; Seemann P; Teng S; Latorre R; Huebner H; Weikert D; Rientjes J; Veldhuis NA; Poole DP; Jensen DD; Thomsen ARB; Schmidt BL; Imlach WL; Gmeiner P; Bunnett NW
Proc Natl Acad Sci U S A; 2023 May; 120(22):e2220979120. PubMed ID: 37216510
[TBL] [Abstract][Full Text] [Related]
4. A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain.
Ramírez-García PD; Retamal JS; Shenoy P; Imlach W; Sykes M; Truong N; Constandil L; Pelissier T; Nowell CJ; Khor SY; Layani LM; Lumb C; Poole DP; Lieu T; Stewart GD; Mai QN; Jensen DD; Latorre R; Scheff NN; Schmidt BL; Quinn JF; Whittaker MR; Veldhuis NA; Davis TP; Bunnett NW
Nat Nanotechnol; 2019 Dec; 14(12):1150-1159. PubMed ID: 31686009
[TBL] [Abstract][Full Text] [Related]
5. Sustained endosomal release of a neurokinin-1 receptor antagonist from nanostars provides long-lasting relief of chronic pain.
Latorre R; Ramírez-Garcia PD; Hegron A; Grace JL; Retamal JS; Shenoy P; Tran M; Aurelio L; Flynn B; Poole DP; Klein-Cloud R; Jensen DD; Davis TP; Schmidt BL; Quinn JF; Whittaker MR; Veldhuis NA; Bunnett NW
Biomaterials; 2022 Jun; 285():121536. PubMed ID: 35533442
[TBL] [Abstract][Full Text] [Related]
6. Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission.
Yarwood RE; Imlach WL; Lieu T; Veldhuis NA; Jensen DD; Klein Herenbrink C; Aurelio L; Cai Z; Christie MJ; Poole DP; Porter CJH; McLean P; Hicks GA; Geppetti P; Halls ML; Canals M; Bunnett NW
Proc Natl Acad Sci U S A; 2017 Nov; 114(46):12309-12314. PubMed ID: 29087309
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-converting enzyme 1 and β-arrestins exert spatiotemporal control of substance P-induced inflammatory signals.
Jensen DD; Halls ML; Murphy JE; Canals M; Cattaruzza F; Poole DP; Lieu T; Koon HW; Pothoulakis C; Bunnett NW
J Biol Chem; 2014 Jul; 289(29):20283-94. PubMed ID: 24898255
[TBL] [Abstract][Full Text] [Related]
8. Recycling and resensitization of the neurokinin 1 receptor. Influence of agonist concentration and Rab GTPases.
Roosterman D; Cottrell GS; Schmidlin F; Steinhoff M; Bunnett NW
J Biol Chem; 2004 Jul; 279(29):30670-9. PubMed ID: 15128739
[TBL] [Abstract][Full Text] [Related]
9. Time-course of the internalization and recycling of neurokinin 1 receptors in rat dorsal horn neurons.
Wang X; Marvizón JC
Brain Res; 2002 Jul; 944(1-2):239-47. PubMed ID: 12106686
[TBL] [Abstract][Full Text] [Related]
10. Chaiqin chengqi decoction ameliorates acute pancreatitis in mice via inhibition of neuron activation-mediated acinar cell SP/NK1R signaling pathways.
Han C; Du D; Wen Y; Li J; Wang R; Jin T; Yang J; Shi N; Jiang K; Deng L; Fu X; Mukherjee R; Windsor JA; Hong J; Phillips AR; Sutton R; Huang W; Liu T; Xia Q
J Ethnopharmacol; 2021 Jun; 274():114029. PubMed ID: 33731310
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling.
Roosterman D; Cottrell GS; Padilla BE; Muller L; Eckman CB; Bunnett NW; Steinhoff M
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11838-43. PubMed ID: 17592116
[TBL] [Abstract][Full Text] [Related]
12. Inflammation-induced abnormalities in the subcellular localization and trafficking of the neurokinin 1 receptor in the enteric nervous system.
Poole DP; Lieu T; Pelayo JC; Eriksson EM; Veldhuis NA; Bunnett NW
Am J Physiol Gastrointest Liver Physiol; 2015 Aug; 309(4):G248-59. PubMed ID: 26138465
[TBL] [Abstract][Full Text] [Related]
13. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-converting enzyme-1 regulates trafficking and signalling of the neurokinin 1 receptor in endosomes of myenteric neurones.
Pelayo JC; Poole DP; Steinhoff M; Cottrell GS; Bunnett NW
J Physiol; 2011 Nov; 589(Pt 21):5213-30. PubMed ID: 21878523
[TBL] [Abstract][Full Text] [Related]
15. Substance P dependence of endosomal fusion during bladder inflammation.
Hammond TG; Saban R; Bost KL; Harris HW; Kaysen JH; Goda FO; Wang XC; Lewis FC; Navar GL; Campbell WC; Bjorling DE; Saban M; Zeidel ML
Am J Physiol Renal Physiol; 2000 Mar; 278(3):F440-51. PubMed ID: 10710549
[TBL] [Abstract][Full Text] [Related]
16. Dynamin and Rab5a-dependent trafficking and signaling of the neurokinin 1 receptor.
Schmidlin F; Dery O; DeFea KO; Slice L; Patierno S; Sternini C; Grady EF; Bunnett NW
J Biol Chem; 2001 Jul; 276(27):25427-37. PubMed ID: 11306580
[TBL] [Abstract][Full Text] [Related]
17. Heterologous regulation of trafficking and signaling of G protein-coupled receptors: beta-arrestin-dependent interactions between neurokinin receptors.
Schmidlin F; Déry O; Bunnett NW; Grady EF
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3324-9. PubMed ID: 11880656
[TBL] [Abstract][Full Text] [Related]
18. Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells.
Garnier A; Vykoukal J; Hubertus J; Alt E; von Schweinitz D; Kappler R; Berger M; Ilmer M
Int J Oncol; 2015 Jul; 47(1):151-60. PubMed ID: 25998227
[TBL] [Abstract][Full Text] [Related]
19. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
[TBL] [Abstract][Full Text] [Related]
20. Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice.
Li Q; Wu X; Yang Y; Zhang Y; He F; Xu X; Zhang Z; Tao L; Luo C
Int J Biochem Cell Biol; 2019 Feb; 107():154-165. PubMed ID: 30593954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
